2017-03-26,Why Concert Pharmaceuticals Is Music to Investors' Ears
2017-03-06,What You Must Know About Cystic Fibrosis Drug CTP-656
2017-03-06,Vertex Pharma Acquires Long-Acting Version of Cystic Fibrosis Drug From Concert Pharma
2017-03-06,Vertex To Acquire CTP-656 From Concert Pharmaceuticals For The Treatment Of Cystic Fibrosis
2017-03-02,Vertex To Present At The Cowen Healthcare Conference On March 6
2017-02-21,Activist Investors Shake Up the Boards at Tiffany &amp; Bristol-Myers Squibb
2017-01-31,Unlike Silicon Valley, Biopharma's Top Execs React to Trump Migration Ban With Universal Silence
2017-01-27,Premarket Biotech Movers: Neurocrine Biosciences, Aralez Pharmaceuticals, Qiagen
2017-01-25,Vertex Reports Full-Year And Fourth-Quarter 2016 Financial Results
2017-01-11,Merck KGaA, Darmstadt, Germany Licenses Four Oncology Research And Development Programs From Vertex
2017-01-09,Monday's Sights, Sounds and Biotech Buzz From the J.P. Morgan Healthcare Conference
2017-01-09,Vertex Pharmaceuticals to Rely on Acquisitions to Diversify Its Business
2017-01-09,Vertex Pharma Will Use Deals to Diversify Beyond Cystic Fibrosis
2017-01-09,Vertex Pharmaceuticals Sees Sales of Cystic Fibrosis Drug Lower Than Expected
2017-01-08,Vertex View into Cystic Fibrosis Sales Growth Still Limited by European Reimbursement
2017-01-08,Vertex Provides Update On Business And Financial Performance And Research And Development Programs
2017-01-07,Here Are 6 Things to Watch Out for at J.P. Morgan's Healthcare Conference Next Week
2017-01-05,Here's What to Look for at the J.P. Morgan Healthcare Conference
2017-01-05,What Biotech Investors Can Expect From the J.P. Morgan Health Care Conference 2017
2017-01-04,Vertex Announces Upcoming Presentation At The J.P. Morgan Healthcare Conference And Date Of Fourth Quarter And Full Year 2016 Financial Results
2017-01-03,Cramer's 'Mad Money' Recap (Tuesday 1/3/17): Better Buying Opportunities Are Lurking
2017-01-03,Cramer: Reviewing S&amp;P's Hit-and-Miss Parade
2017-01-03,17 Thoughts on Biotech Stocks to Kick Off 2017
2016-12-19,Vertex Announces German Reimbursement Agreement For ORKAMBI® (Lumacaftor/Ivacaftor), The First Medicine To Treat The Underlying Cause Of Cystic Fibrosis In People Ages 12 And Older With Two Copies Of The F508del Mutation
2016-12-12,Vertex Pharmaceuticals Becomes #42 Most Shorted Nasdaq 100 Component, Replacing Cerner
2016-12-09,Broadcom Call Should 'Make You Feel Better About Owning Apple': More Squawk From Jim Cramer
2016-11-29,More Base Building Ahead for Vertex Pharmaceuticals
2016-11-29,Analysts' Actions -- Goldman Sachs, Johnson & Johnson, Pfizer and More
2016-11-17,Hey Gilead, Stop Developing Drugs and Start Buying Biotech Companies -- Now!
2016-11-14,Bullish and Bearish Chart Reversals
2016-11-13,Six Thoughts on President Trump and the Durability of the Biotech Stock Rally
2016-11-10,5 Health Care Stocks Set to Bounce
2016-11-07,Positive Phase 3 Study Of ORKAMBI® In Children With Cystic Fibrosis Ages 6-11 Who Have Two Copies Of The F508del Mutation Supports A Submission To The European Medicines Agency In The First Half Of 2017
2016-11-02,Vertex To Present At The Credit Suisse Healthcare Conference On November 8
2016-10-27,Vertex Pharmaceuticals Enters Oversold Territory
2016-10-27,ProQR Cystic Fibrosis Drug Passes First, Early Efficacy Test
2016-10-27,Vertex Presents Long-Term Data Demonstrating That ORKAMBI® (lumacaftor/ivacaftor) And KALYDECO® (ivacaftor) Show The Potential To Modify The Progression Of CF
2016-10-26,Vertex Pharma (VRTX) Stock Lower on Q3 Miss
2016-10-26,Pardon Me, but I Have a Few Things to Say... Vertex, Biogen, Ariad, Sarepta
2016-10-25,Vertex Pharma Moves Next-Generation Cystic Fibrosis Drugs Into New Clinical Trials
2016-10-25,Vertex Reports Third Quarter 2016 Financial Results
2016-10-25,Table 1 (Graphic: Vertex)
2016-10-11,Illumina Leads Healthcare Selloff, Abbott and Zimmer Also Fall
2016-10-07,Vertex To Announce Third Quarter 2016 Financial Results On October 25
2016-10-05,When Does Vertex Pharmaceuticals Become a Buy?
2016-09-28,U.S. Food And Drug Administration Approves ORKAMBI® (lumacaftor/ivacaftor) For Use In Children With Cystic Fibrosis Ages 6 Through 11 Who Have Two Copies Of The F508del Mutation
2016-09-09,Vertex To Present At Upcoming Investor Conferences
2016-08-25,Vertex Pharmaceuticals Takes Over #81 Spot From Starbucks
2016-08-15,Vertex Provides Update On Ongoing Phase 3 Program For VX-661 In Combination With Ivacaftor For The Treatment Of Cystic Fibrosis
2016-08-07,Listen Up and Pay Attention to the Utes
2016-08-01,Could a Spin-off of its Hepatitis C Division be in Gilead's Future?
2016-07-28,Ratings Changes Today
2016-07-27,Vertex Reports Second Quarter 2016 Financial Results
2016-07-27,A 'Semi-Charmed' Kind of NXPI Call Spread
2016-07-14,Vertex To Announce Second Quarter 2016 Financial Results On July 27
2016-07-13,3 Stocks Pushing The Health Care Sector Lower
2016-07-06,Wall Street Closes Higher as Fed Doves Make Case for Waiting on Rates
2016-07-06,Stocks Add to Gains as Fed Stresses Prudence in Policy-Making
2016-07-06,Vertex And Moderna Establish Exclusive Collaboration To Discover And Develop MRNA Therapeutics™ For Cystic Fibrosis
2016-07-01,Biotech Stock Mailbag: Mid-Year Assessment, Where We Go From Here
2016-06-27,The New #41 Most Shorted Nasdaq 100 Component: Vertex Pharmaceuticals
2016-06-10,Vertex Announces Presentations Of Data For KALYDECO® (ivacaftor) And ORKAMBI® (lumacaftor/ivacaftor) At European Cystic Fibrosis Society (ECFS) Conference
2016-06-10,Biotech Stock Mailbag: Sarepta! Always More Sarepta. And Gilead, Too
2016-06-09,3 Stocks Pulling The Health Care Sector Downward
2016-05-31,Vertex To Present At The Goldman Sachs Healthcare Conference On June 7
2016-05-31,U.S. FDA Accepts For Priority Review Supplemental New Drug Application For The Use Of ORKAMBI® (lumacaftor/ivacaftor) In Children With Cystic Fibrosis Ages 6 To 11 Who Have Two Copies Of The F508del Mutation
2016-05-25,Vertex Pharmaceuticals Becomes #243 Most Shorted S&P 500 Component, Replacing Coach
2016-05-09,Cramer: How Did the Stock Market Get So Unwieldy?
2016-04-27,Vertex Forecasts Billion-Dollar Sales for Cystic Fibrosis Drug in '16
2016-04-27,Post-Market Activity Shows Vertex Pharmaceuticals (VRTX) Down
2016-04-27,Vertex Reports First Quarter 2016 Financial Results
2016-04-27,Charts Say Vertex Could Recover
2016-04-22,3 Compelling Reasons to Buy This Undervalued Biotechnology Stock
2016-04-22,5 Toxic Stocks You Should Sell Now
2016-04-18,Enterome In-licenses Novel Compounds From Vertex Pharmaceuticals To Treat Microbiome-related Inflammatory Bowel Diseases
2016-04-18,Strong On High Relative Volume: Vertex Pharmaceuticals (VRTX)
2016-04-15,Vertex To Announce First Quarter 2016 Financial Results On April 27
2016-04-12,Vertex Pharma (VRTX) Stock Price Target Cut at Credit Suisse
2016-04-07,Perilous Reversal Watch: Vertex Pharmaceuticals (VRTX)
2016-04-07,Vertex Pharmaceuticals (VRTX) Stock Receives &lsquo;Market Perform&rsquo; Rating at BMO Capital
2016-04-06,Vertex Pharmaceuticals (VRTX) Stock Price Target Reduced at Jefferies
2016-04-04,Reasons for Vertex's Stock Slump Since Last Summer Center on Orkambi Launch
2016-03-29,3 Stocks Pushing The Drugs Industry Downward
2016-03-27,5 Stocks That Could Be Toxic to Your Portfolio in 2016
2016-03-23,NVO, VRTX And ILMN, Pushing Health Care Sector Downward
2016-03-10,Vertex To Present At The Barclays Healthcare Conference On March 15
2016-03-10,3 Stocks Pulling The Drugs Industry Downward
2016-03-08,Vertex Receives Australian Approval For ORKAMBI® (lumacaftor/ivacaftor), The First Medicine To Treat The Underlying Cause Of Cystic Fibrosis In People Ages 12 And Older With Two Copies Of The F508del Mutation
2016-03-06,JPMorgan's 7 Best Stock Picks With Near-Term Catalysts
2016-03-02,3 Stocks Advancing The Drugs Industry
2016-02-25,3 Stocks Pushing The Drugs Industry Downward
2016-02-24,Vertex Awards $1 Million In Grants To 18 Non-profit Organizations To Advance Initiatives For People Living With Cystic Fibrosis
2016-02-20,10 Big CEOs Who Make Way Too Much Money
2016-02-09,Vertex To Present At Upcoming Investor Conferences
2016-02-05,Vertex Receives Complete Response Letter From U.S. FDA For Use Of KALYDECO® (ivacaftor) In People With Cystic Fibrosis Ages 2 And Older With One Of 23 Residual Function Mutations
2016-02-01,Analysts' Actions -- Bristol-Myers, Chipotle, Monster Beverage, Vertex Pharmaceuticals and More
2016-02-01,Biotech String: Assessing the January Damage, Gilead's Bottoming P/E, Sarepta Panel Date?
2016-01-29,Here Are the 5 Worst-Performing Stocks in the S&amp;P 500 in 2016
2016-01-27,Vertex Pharmaceuticals (VRTX) Is Today's Post-Market Loser Stock
2016-01-27,Vertex Reports Full-Year And Fourth Quarter 2015 Financial Results
2016-01-26,Health Canada Approves PrORKAMBI® (lumacaftor/ivacaftor) - The First Medicine To Treat The Underlying Cause Of Cystic Fibrosis For People Ages 12 And Older With Two Copies Of The F508del Mutation
2016-01-25,Biotech String: Editas IPO Terms, Rooting for Shkreli in DC
2016-01-15,Vertex Pharmaceuticals (VRTX) Showing Signs Of Perilous Reversal Today
2016-01-14,Here Are the 10 Worst S&P 500 Stocks So Far in 2016
2016-01-12,3 Stocks Pulling The Drugs Industry Downward
2016-01-11,A Lack of News and Buzz at 'JPM16' Sinks Biotech Stocks
2016-01-10,Vertex Takes a Pass on 2016 Orkambi Cystic Fibrosis Sales Guidance
2016-01-10,Vertex Outlines 2016 Business Priorities To Support The Discovery And Development Of New Transformative Medicines For The Treatment Of Cystic Fibrosis And Other Serious Diseases
2016-01-09,5 Toxic Stocks to Sell in January
2016-01-05,Vertex Announces Upcoming Presentation At The J.P. Morgan Healthcare Conference And Date Of Fourth Quarter And Full Year 2015 Financial Results
2015-12-26,Sell These 6 Biotech Stocks Now Before It's Too Late
2015-12-08,J.P. Morgan's 53 Top Stock Picks for 2016
2015-12-04,Today's Dead Cat Bounce Stock Is Vertex Pharmaceuticals (VRTX)
2015-12-03,3 Drugs Stocks Dragging The Industry Down
2015-12-01,'Mad Money' Lightning Round: Buy Kroger, It's Terrific
2015-11-30,Jim Cramer's 'Mad Money' Recap: These Retailers Will Survive the Amazon Express
2015-11-23,Vertex To Present At The Piper Jaffray Healthcare Conference On December 1
2015-11-23,Vertex Appoints Michael J. Parini As Executive Vice President And Chief Legal Officer
2015-11-20,Vertex Receives EU Approval For ORKAMBI® (lumacaftor/ivacaftor), The First Medicine To Treat The Underlying Cause Of Cystic Fibrosis In People Ages 12 And Older With Two Copies Of The F508del Mutation
2015-11-18,Vertex Receives Two EU Approvals For KALYDECO® (ivacaftor) For People With Cystic Fibrosis
2015-11-13,3 Stocks Raising The Drugs Industry Higher
2015-11-04,Vertex To Present At The Credit Suisse Healthcare Conference On November 10
2015-10-30,Analysts' Actions -- Vertex, LinkedIn, BE/Aerospace, DreamWorks, Starbucks
2015-10-28,Vertex Reports Third Quarter 2015 Financial Results
2015-10-28,Trade-Ideas: Vertex Pharmaceuticals (VRTX) Is Today's "Perilous Reversal" Stock
2015-10-28,3 Stocks Underperforming Today In The Health Care Sector
2015-10-26,Vertex And CRISPR Therapeutics Establish Collaboration To Use CRISPR-Cas9 Gene Editing Technology To Discover And Develop New Treatments For Genetic Diseases
2015-10-13,3 Stocks Pulling The Drugs Industry Downward
2015-10-09,Vertex To Announce Third Quarter 2015 Financial Results On October 28
2015-10-08,SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Involving Possible Breaches Of Fiduciary Duty By The Board Of Vertex Pharmaceuticals Incorporated -- VRTX
2015-10-08,Vertex to Test New Cystic Fibrosis Drugs, Seeking Broader, More Effective Treatments
2015-10-08,Vertex Announces Significant Progress In Its Development Efforts To Treat The Cause Of Cystic Fibrosis In The Vast Majority Of People With The Disease
2015-10-07,Supplemental New Drug Application For Use Of KALYDECO® (ivacaftor) In People With Cystic Fibrosis Ages 2 And Older Who Have One Of 23 Residual Function Mutations Accepted For Priority Review By U.S. FDA
2015-10-02,Morgan Stanley Says These 9 Health Care Stocks Are Best-Positioned, Despite Rising Drug Prices
2015-10-02,Analysts' Actions -- Google, Gilead, AIG and More
2015-10-01,10 Worst Health Care Stocks in the Third Quarter
2015-09-30,Strong On High Relative Volume: Vertex Pharmaceuticals (VRTX)
2015-09-25,Vertex Receives CHMP Positive Opinions For ORKAMBI™ (lumacaftor/ivacaftor) And KALYDECO® (ivacaftor) In The European Union
2015-09-23,3 Stocks Dragging The Health Care Sector Downward
2015-09-22,Analysts Say Buy Select Biotech Stocks Ahead Of Clinton Drug Plan
2015-09-22,Clinton Drug Plan Cuts Market Exclusivity, Sets Mandatory R&D Spending
2015-09-18,Roof Leaker To Watch: Vertex Pharmaceuticals (VRTX)
2015-09-18,SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Involving Possible Breaches Of Fiduciary Duty By The Board Of Vertex Pharmaceuticals Incorporated -- VRTX
2015-09-16,3 Stocks Underperforming Today In The Drugs Industry
2015-09-14,Analysts' Actions -- Marvell, Dow Chemical, Other Calls
2015-09-08,Vertex To Present At The Morgan Stanley Healthcare Conference On September 16
2015-08-26,Vertex Pharmaceuticals (VRTX) Is Strong On High Volume Today
2015-08-24,Biotech Stocks Recover From Early-Morning Flash Crash
2015-08-19,Vertex Awards Two Boston Public High School Students The Vertex Science Leaders Scholarship To The University Of Massachusetts
2015-08-14,50 Stocks to Watch for Good Plays: Jim Cramer's Best Blogs
2015-08-14,Expect Bumpy Ride When 'Unicorn' Tech Bubble Pops, Says Avalon Founder
2015-08-04,3 Stocks Boosting The Drugs Industry Higher
2015-07-30,3 Drugs Stocks Pushing Industry Growth
2015-07-29,Trade-Ideas: Vertex Pharmaceuticals (VRTX) Is Today's Post-Market Leader Stock
2015-07-29,Vertex Reports Second Quarter 2015 Financial Results
2015-07-20,Apple's Earnings Could Coincide with an Overbought Reading
2015-07-15,Vertex Pharmaceuticals (VRTX) Is Strong On High Volume Today
2015-07-14,Vertex To Announce Second Quarter 2015 Financial Results On July 29
2015-07-02,Vertex Wins U.S. Approval for New Cystic Fibrosis Drug
2015-07-02,FDA Approves ORKAMBI™ (lumacaftor/ivacaftor) - The First Medicine To Treat The Underlying Cause Of Cystic Fibrosis For People Ages 12 And Older With Two Copies Of The F508del Mutation
2015-07-02,Vertex Pharmaceuticals (VRTX) Is Today's Unusual Social Activity Stock
2015-06-29,Vertex Profits Hinge on FDA Approving New Cystic Fibrosis Drug This Week
2015-06-29,Vertex Pharmaceuticals Becomes #232 Most Shorted S&P 500 Component, Replacing Exxon Mobil
2015-06-25,Trade-Ideas: Vertex Pharmaceuticals (VRTX) Is Today's Post-Market Leader Stock
2015-06-23,3 Stocks Raising The Health Care Sector Higher
2015-06-18,Sangeeta N. Bhatia, M.D., Ph.D., Joins Vertex Board Of Directors
2015-06-11,Vertex Announces Data Presentations At European Cystic Fibrosis Society (ECFS) Conference
2015-06-04,Vertex And Parion Sciences Establish Collaboration To Develop Epithelial Sodium Channel (ENaC) Inhibitors In Cystic Fibrosis And Other Pulmonary Diseases
2015-06-03,Vertex To Present At The Goldman Sachs Healthcare Conference On June 11
2015-06-03,Corbus Focused on Research and in No Hurry for Partnerships, Says CEO
2015-06-03,Corbus Ready to Take Cystic Fibrosis Drug the Distance Says CEO
2015-05-22,Biotech Stock Mailbag: ASCO Preview, CAR-T stocks, MannKind, Hate Mail!
2015-05-20,10 S&P 500 Companies to Have the Most Revenue Growth in 2015
2015-05-19,Gilead Sciences Buying Achillion Was Twitter Speculation at Its Finest
2015-05-17,New England Journal Of Medicine Publishes Data From Two Phase 3 Studies Of ORKAMBITM (lumacaftor/ivacaftor) in People With Cystic Fibrosis Who Have Two Copies Of The F508del Mutation
2015-05-13,Vertex To Present At The UBS Healthcare Conference On May 19
2015-05-13,Vertex Pharmaceuticals (VRTX) Stock Climbs Following FDA Advisory Panel Aprroval
2015-05-13,Cramer: I Like Receptos and Radius, as Well as the Four Horsemen
2015-05-13,Vertex Pharmaceuticals (VRTX) Showing Unusual Social Activity Today
2015-05-12,Food And Drug Administration Advisory Panel Voted 12 To 1 To Recommend Approval Of ORKAMBI™ (lumacaftor/ivacaftor) To Treat People With Cystic Fibrosis Ages 12 And Older Who Have Two Copies Of The F508del Mutation
